Olanzapine vs haloperidol for treatment of schizophrenia.
William M
WM
Glazer
D017109:Akathisia, Drug-Induced / Q000517:prevention & control; D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D001590:Benztropine / Q000627:therapeutic use; D006220:Haloperidol / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D000077152:Olanzapine; D012559:Schizophrenia / Q000188:drug therapy*
D018726:Anti-Dyskinesia Agents; D014150:Antipsychotic Agents; D001569:Benzodiazepines; D001590:Benztropine; D006220:Haloperidol; D000077152:Olanzapine